The short answer
There is no standard medical cannabis dose for autism. No cannabis product is FDA-approved to treat autism spectrum disorder, and the numbers used in research come from a study protocol, not from something you can copy at home. The most-cited range comes from small trials of CBD-rich extracts in children, where researchers started near 1 to 2 mg of CBD per kilogram of body weight per day and raised the amount over several weeks under close supervision. A real plan has to be built by a clinician who knows the patient's age, seizure history, other medications, and state law.
is cannabis safe for autism patients
Why no fixed number exists
Autism is not one condition. Two children with the same diagnosis can respond in opposite ways to the same oil. Add the usual variables: oral absorption is slow and inconsistent, label claims often do not match measured cannabinoid content, and CBD and THC interact with a long list of prescription drugs. A dose that works for one person tells you almost nothing about the next.
What the published research shows
The pediatric literature is small and mostly open-label. A 2019 study of 188 children with ASD used a CBD-rich extract, with doses climbing toward 10 mg/kg/day in some participants, and reported improvement on some parent-rated behavioral measures. There was no placebo group, and side effects such as sleepiness, appetite loss, and diarrhea were common. Later randomized trials have been mixed, with strong placebo responses, which is typical in autism research. Case reports also describe THC worsening agitation, aggression, and psychotic symptoms in some young users.
How clinicians tend to titrate
- Start at the lowest measurable amount, often 0.5 to 1 mg of CBD per kg per day, split into two doses.
- Hold each step for one to two weeks before increasing. Faster changes make side effects impossible to attribute.
- Favor CBD-dominant or CBD-only products for children. Ratios with meaningful THC get avoided.
- Change one variable at a time: dose, product, or timing, never all three in the same week.
- Keep a daily log of sleep, appetite, irritability, and seizures so the effect can be judged against a baseline.
Age changes the calculation
An adult with autism has room to try products a child cannot. A five-year-old does not. The American Academy of Pediatrics advises against cannabis use in children and adolescents outside of research, mainly over concerns about brain development, memory, attention, and dependency risk. That guidance does not disappear because a parent is desperate, and any pediatric trial of cannabis should run through a physician who is documenting outcomes.
Can Medical Cannabis Help Autism?
Drug interactions worth knowing
CBD inhibits several cytochrome P450 enzymes. That matters most with clobazam, where CBD raises the active metabolite and can double sedation, and with valproate, where liver enzymes need monitoring. Also on the list: risperidone, aripiprazole, some antiseizure drugs, and certain antidepressants. Bloodwork for liver function is reasonable before starting and after major dose changes.
What a responsible plan includes
- A diagnosis confirmed by a developmental pediatrician, psychiatrist, or neurologist, not by a dispensary employee.
- Signed consent and a caregiver willing to track daily data.
- One product from one licensed manufacturer, with a batch lab report for potency and contaminants.
- Scheduled follow-ups, and a clear rule for stopping if behavior, sleep, or liver panels worsen.
Questions to bring to the appointment
- What is our target dose in milligrams, and what is the ceiling?
- How do we measure a dose accurately with this product's concentration?
- Which of my child's current medications interact with CBD?
- What symptoms would make us pause or stop?
- How long before we judge whether this is helping?
Cannabis can be part of a care plan, but it is not a shortcut past behavioral therapy, sleep support, and the medications that already have evidence behind them.